133 related articles for article (PubMed ID: 30517141)
21. [Stomal Cancer Recurrency, A Clinic-Pathological Consideration].
Teutsch S; Bas M; Bier H; Knopf A
Laryngorhinootologie; 2017 Apr; 96(4):239-243. PubMed ID: 27846642
[No Abstract] [Full Text] [Related]
22. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
23. Routine panendoscopy in oral squamous cell cancer patients: mandatory or facultative?
Valentin A; Goetz M; Hetzel J; Reinert S; Hoefert S
Clin Oral Investig; 2021 Mar; 25(3):1245-1254. PubMed ID: 32607829
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profile in site-specific head and neck squamous cell cancer.
Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
[TBL] [Abstract][Full Text] [Related]
25. Readmission following primary surgery for larynx and oropharynx cancer in the elderly.
Chaudhary H; Stewart CM; Webster K; Herbert RJ; Frick KD; Eisele DW; Gourin CG
Laryngoscope; 2017 Mar; 127(3):631-641. PubMed ID: 27659029
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
27. Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy.
Su YY; Fang FM; Chuang HC; Luo SD; Chien CY
Head Neck; 2010 Jun; 32(6):780-5. PubMed ID: 19890910
[TBL] [Abstract][Full Text] [Related]
28. [Tracheostomy in patients with locally advanced laryngeal cancer].
Chernov NV; Klochikhin AL; Markov GI
Vestn Otorinolaringol; 2005; (2):52-4. PubMed ID: 16025937
[TBL] [Abstract][Full Text] [Related]
29. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma.
Lee DS; Lee JJ; Sinha P; Puram SV; Jackson RS; Adkins DR; Oppelt P; Brenneman R; Thorstad WL; Pipkorn P
Laryngoscope; 2023 Mar; 133(3):594-600. PubMed ID: 35611799
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy.
Basheeth N; O'Leary G; Khan H; Sheahan P
Head Neck; 2015 Jun; 37(6):862-9. PubMed ID: 24623609
[TBL] [Abstract][Full Text] [Related]
32. Predictors and outcomes for chronic tracheostomy after chemoradiation for advanced laryngohypopharyngeal cancer.
Jefferson GD; Wenig BL; Spiotto MT
Laryngoscope; 2016 Feb; 126(2):385-91. PubMed ID: 26344401
[TBL] [Abstract][Full Text] [Related]
33. Analysis of preoperative serum levels of MMP1, -2, and -9 in patients with site-specific head and neck squamous cell cancer.
Kalfert D; Ludvikova M; Topolcan O; Windrichova J; Malirova E; Pesta M; Celakovsky P
Anticancer Res; 2014 Dec; 34(12):7431-41. PubMed ID: 25503184
[TBL] [Abstract][Full Text] [Related]
34. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
35. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
[TBL] [Abstract][Full Text] [Related]
36. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
37. What patients consider important: temporal variations by early and late stage oral, oropharyngeal and laryngeal subsites.
Metcalfe CW; Lowe D; Rogers SN
J Craniomaxillofac Surg; 2014 Jul; 42(5):641-7. PubMed ID: 24238983
[TBL] [Abstract][Full Text] [Related]
38. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
39. The role of selective neck dissection in pathological N1 squamous cell carcinomas of the head and neck.
Yıldırım T; Ozmen OA; Erişen L; Kasapoğlu F; Coşkun H; Basut O; Onart S; Hızalan I
Kulak Burun Bogaz Ihtis Derg; 2011; 21(2):63-9. PubMed ID: 21417967
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
